- Home
- PLUR vs ABVC Comparison
PLUR vs ABVC Comparison
Compare PLUR & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- ABVC
- Stock Information
- Founded
- PLUR 2001
- ABVC 2015
- Country
- PLUR Israel
- ABVC United States
- Employees
- PLUR N/A
- ABVC N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- PLUR Health Care
- ABVC Health Care
- Exchange
- PLUR Nasdaq
- ABVC Nasdaq
- Market Cap
- PLUR 44.7M
- ABVC 52.1M
- IPO Year
- PLUR N/A
- ABVC N/A
- Fundamental
- Price
- PLUR $4.70
- ABVC $2.86
- Analyst Decision
- PLUR Strong Buy
- ABVC
- Analyst Count
- PLUR 1
- ABVC 0
- Target Price
- PLUR $12.00
- ABVC N/A
- AVG Volume (30 Days)
- PLUR 11.7K
- ABVC 82.7K
- Earning Date
- PLUR 11-11-2025
- ABVC 11-13-2025
- Dividend Yield
- PLUR N/A
- ABVC N/A
- EPS Growth
- PLUR N/A
- ABVC N/A
- EPS
- PLUR N/A
- ABVC N/A
- Revenue
- PLUR $1,034,000.00
- ABVC $391,242.00
- Revenue This Year
- PLUR $395.40
- ABVC $735.18
- Revenue Next Year
- PLUR $186.32
- ABVC N/A
- P/E Ratio
- PLUR N/A
- ABVC N/A
- Revenue Growth
- PLUR 203.23
- ABVC 186.84
- 52 Week Low
- PLUR $3.33
- ABVC $0.40
- 52 Week High
- PLUR $7.13
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- PLUR 45.12
- ABVC 49.97
- Support Level
- PLUR $4.33
- ABVC $2.64
- Resistance Level
- PLUR $4.96
- ABVC $2.90
- Average True Range (ATR)
- PLUR 0.27
- ABVC 0.16
- MACD
- PLUR -0.02
- ABVC 0.01
- Stochastic Oscillator
- PLUR 38.14
- ABVC 55.64
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.